FR2227276A1 - Non-toxic nitrogen-active blood serum fractions - for culture of human diploid fibro-blasts, are prepd. by fractionation using ultrafiltration membrane sieves - Google Patents

Non-toxic nitrogen-active blood serum fractions - for culture of human diploid fibro-blasts, are prepd. by fractionation using ultrafiltration membrane sieves

Info

Publication number
FR2227276A1
FR2227276A1 FR7414869A FR7414869A FR2227276A1 FR 2227276 A1 FR2227276 A1 FR 2227276A1 FR 7414869 A FR7414869 A FR 7414869A FR 7414869 A FR7414869 A FR 7414869A FR 2227276 A1 FR2227276 A1 FR 2227276A1
Authority
FR
France
Prior art keywords
prepd
culture
ultrafiltration membrane
fibro
blasts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7414869A
Other languages
French (fr)
Other versions
FR2227276B3 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RES FOUNDATION CHILDREN S
Original Assignee
RES FOUNDATION CHILDREN S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RES FOUNDATION CHILDREN S filed Critical RES FOUNDATION CHILDREN S
Publication of FR2227276A1 publication Critical patent/FR2227276A1/en
Application granted granted Critical
Publication of FR2227276B3 publication Critical patent/FR2227276B3/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mitogen-active bloodserum fractions, free from viral substances and cytotoxic factors, are prepd. from blood serum of mammalian origin, using ultrafiltration membrane sieves, discarding all components of mol. wt. >300,000 and 50,000. The serum may be used in tissue culture media for the growth and culture of cells, esp. human diploid fibroblasts. The product can be prepd. cheaply and in large quantities from any source of animal or human blood.
FR7414869A 1973-04-27 1974-04-29 Non-toxic nitrogen-active blood serum fractions - for culture of human diploid fibro-blasts, are prepd. by fractionation using ultrafiltration membrane sieves Granted FR2227276A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35497173A 1973-04-27 1973-04-27

Publications (2)

Publication Number Publication Date
FR2227276A1 true FR2227276A1 (en) 1974-11-22
FR2227276B3 FR2227276B3 (en) 1977-03-04

Family

ID=23395684

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7414869A Granted FR2227276A1 (en) 1973-04-27 1974-04-29 Non-toxic nitrogen-active blood serum fractions - for culture of human diploid fibro-blasts, are prepd. by fractionation using ultrafiltration membrane sieves

Country Status (6)

Country Link
JP (1) JPS5029739A (en)
AU (1) AU6837174A (en)
DE (1) DE2420415A1 (en)
FR (1) FR2227276A1 (en)
IL (1) IL44725A0 (en)
NL (1) NL7405707A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2416690A1 (en) * 1978-02-14 1979-09-07 Cantacuzino Inst Antirheumatic and antiinflammatory protein soln. - produced by acidic partial hydrolysis of normal horse serum
EP0148770A2 (en) * 1984-01-07 1985-07-17 Director-General Of The Agency Of Industrial Science And Technology Composition for cell cultivation, production and use thereof
FR2563532A1 (en) * 1984-04-25 1985-10-31 Pasteur Institut Mitogenic compositions, a process for preparing them and their application to cell culture media.
US11604026B2 (en) 2019-03-14 2023-03-14 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11634257B2 (en) 2017-10-09 2023-04-25 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI884108A (en) * 1987-09-08 1989-03-09 Solco Basel Ag FOERFARANDE FOER FOEROEKNING OCH BEVARING AV DJURCELLER I MASSKULTUR.
DE10003811A1 (en) * 2000-01-28 2001-08-09 Sanorell Pharma Gmbh & Co Process for the production of a serum-containing culture medium for cells and its use

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2416690A1 (en) * 1978-02-14 1979-09-07 Cantacuzino Inst Antirheumatic and antiinflammatory protein soln. - produced by acidic partial hydrolysis of normal horse serum
EP0148770A2 (en) * 1984-01-07 1985-07-17 Director-General Of The Agency Of Industrial Science And Technology Composition for cell cultivation, production and use thereof
EP0148770A3 (en) * 1984-01-07 1986-08-20 Director-General Of The Agency Of Industrial Science And Technology Composition for cell cultivation, production and use thereof
FR2563532A1 (en) * 1984-04-25 1985-10-31 Pasteur Institut Mitogenic compositions, a process for preparing them and their application to cell culture media.
US11634257B2 (en) 2017-10-09 2023-04-25 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
US11604026B2 (en) 2019-03-14 2023-03-14 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11609043B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use
US11609042B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
US11740019B2 (en) 2019-03-14 2023-08-29 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11747082B2 (en) 2019-03-14 2023-09-05 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
US11815311B2 (en) 2019-03-14 2023-11-14 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use
US11994343B2 (en) 2019-03-14 2024-05-28 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use

Also Published As

Publication number Publication date
JPS5029739A (en) 1975-03-25
IL44725A0 (en) 1974-06-30
FR2227276B3 (en) 1977-03-04
NL7405707A (en) 1974-10-29
DE2420415A1 (en) 1974-11-14
AU6837174A (en) 1975-10-30

Similar Documents

Publication Publication Date Title
ES524986A0 (en) METHOD OF OBTAINING THE SQUEEZE OF A SELECTED MATTER CONTAINING RENINE.
ATE94553T1 (en) PROCEDURE FOR ISOLATION OF LONG-CHAIN NUCLEIC ACID.
HK1142093A1 (en) Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
Ebeling A ten year old strain of fibroblasts
PT88626A (en) PROCESS FOR THE PREPARATION OF A POLYPEPTIDE GROWTH FACTORMILK
DE69109886T2 (en) Process for the preparation of human factor VIII and its analogs.
PT83255A (en) Process for the preparation of polypeptides and characteristic antibodies of papillomavirus and diagnostic method thereto
FR2227276A1 (en) Non-toxic nitrogen-active blood serum fractions - for culture of human diploid fibro-blasts, are prepd. by fractionation using ultrafiltration membrane sieves
ATE92720T1 (en) WHEY MODIFICATION PROCESS.
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
EP0306219A3 (en) Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
DE69023648D1 (en) PRODUCTION OF A VIRUS AND CLEANING OF VIRUS COATING PROTEINS FOR VACCINE USE.
C ANDREW BASSETT et al. Characteristics and potentials of long term cultures of human skin
GB1312877A (en) Whey treatment process and product
GB1469901A (en) Process for obtaining virus proteins
DE59310192D1 (en) Lignin polymer composition for the treatment of skin problems
EP0373497A3 (en) Dipeptide derivatives with an enzyme-inhibiting activity
EP0148770B1 (en) Composition for cell cultivation, production and use thereof
GB1278967A (en) Dental implants
DE69116240T2 (en) Process for the production of cell protein with anti-HIV activity
Neumeier et al. Two different types of granulocyte colony-stimulating factor produced by bovine lung tissue
JPS6434284A (en) Culture medium for animal cell
FR2055537A5 (en) Separation of pure proteins
FR2333516A1 (en) Protamine zinc insulin additives - to tissue culture media for prepn of viral vaccines esp mumps and german measles
Johnson CYTOTOXIC FACTORS FROM MARMOSET MONKEY NK-LIKE CELL LINES1

Legal Events

Date Code Title Description
ST Notification of lapse